Trial intelligence / Profile preview

Erythromycin for treatment of cyclic vomiting syndrome in children

IRCT2014071418472N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of erythromycin in cyclic vomiting syndrome (CVS), sponsored by Shiraz University of Medical Sciences. Started Mar 2014; status: completed.

02

Drugs

erythromycin
03

Conditions

cyclic vomiting syndrome (CVS)

Beyond the preview

Go deeper on IRCT2014071418472N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014071418472N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call